1.
CRB1 -associated retinal dystrophies in a Belgian cohort: genetic characteristics and long-term clinical follow-up.
Talib Mays, Van Cauwenbergh Caroline, De Zaeytijd Julie, Van Wynsberghe David, De Baere Elfride, Boon Camiel J F et al.
Br J OphthalmolFeb 202128 citationsCohort Study
CRB1 retinal dystrophies are progressive, causing early macular damage, with a potential gene therapy window before age 40 for RP and age 10 for LCA.